Longitudinal change in basal ganglia volume in patients with Huntington's disease - PubMed (original) (raw)
Longitudinal change in basal ganglia volume in patients with Huntington's disease
E H Aylward et al. Neurology. 1997 Feb.
Abstract
Cross-sectional MRI studies demonstrating an association between caudate atrophy and symptom severity and duration of symptoms in patients with Huntington's disease (HD) have been assumed to reflect longitudinal changes in basal ganglia, but such neuropathologic progression has never been directly demonstrated. Subjects in the current study were 23 HD patients at various stages of the disorder who had two MRI images at least 10 months apart (mean interimage interval = 20.8 months). We measured volumes of caudate, putamen, and globus pallidus blind to the order of the images. For each structure, we calculated a change score by subtracting the volume obtained on the follow-up imaging from that obtained on the initial imaging. Results indicated significant decreases over time in caudate, putamen, and total basal ganglia volume. Age at onset and length of trinucleotide repeat correlated significantly with amount of volume change in caudate and total basal ganglia, even after controlling for length of interimage interval, duration of disease, and measures of symptom severity. Amount of change in basal ganglia structures was not significantly correlated with neurologic symptom severity at the time of the initial imaging or duration of symptoms. This is the first longitudinal MRI study to document progressive basal ganglia atrophy in HD, and suggests that quantitative neuroimaging with serial MRI may be useful in monitoring effectiveness of potential treatments. In addition, demonstration of greater rate of basal ganglia atrophy in patients with earlier symptom onset suggests that treatment effects may be more quickly observed in this subgroup of patients than in the general HD population.
Similar articles
- Reduced basal ganglia volume associated with the gene for Huntington's disease in asymptomatic at-risk persons.
Aylward EH, Brandt J, Codori AM, Mangus RS, Barta PE, Harris GJ. Aylward EH, et al. Neurology. 1994 May;44(5):823-8. doi: 10.1212/wnl.44.5.823. Neurology. 1994. PMID: 8190282 - Basal ganglia volume and proximity to onset in presymptomatic Huntington disease.
Aylward EH, Codori AM, Barta PE, Pearlson GD, Harris GJ, Brandt J. Aylward EH, et al. Arch Neurol. 1996 Dec;53(12):1293-6. doi: 10.1001/archneur.1996.00550120105023. Arch Neurol. 1996. PMID: 8970459 - Basal ganglia atrophy in prodromal Huntington's disease is detectable over one year using automated segmentation.
Majid DS, Aron AR, Thompson W, Sheldon S, Hamza S, Stoffers D, Holland D, Goldstein J, Corey-Bloom J, Dale AM. Majid DS, et al. Mov Disord. 2011 Dec;26(14):2544-51. doi: 10.1002/mds.23912. Epub 2011 Sep 19. Mov Disord. 2011. PMID: 21932302 Free PMC article. Clinical Trial. - Structural neuroimaging of the basal ganglia in schizophrenic patients: a review.
Brandt GN, Bonelli RM. Brandt GN, et al. Wien Med Wochenschr. 2008;158(3-4):84-90. doi: 10.1007/s10354-007-0478-7. Wien Med Wochenschr. 2008. PMID: 18330524 Review. - An overview of psychiatric symptoms in Huntington's disease.
Anderson KE, Marder KS. Anderson KE, et al. Curr Psychiatry Rep. 2001 Oct;3(5):379-88. doi: 10.1007/s11920-996-0030-2. Curr Psychiatry Rep. 2001. PMID: 11559474 Review.
Cited by
- Topography of cerebral atrophy in early Huntington's disease: a voxel based morphometric MRI study.
Kassubek J, Juengling FD, Kioschies T, Henkel K, Karitzky J, Kramer B, Ecker D, Andrich J, Saft C, Kraus P, Aschoff AJ, Ludolph AC, Landwehrmeyer GB. Kassubek J, et al. J Neurol Neurosurg Psychiatry. 2004 Feb;75(2):213-20. J Neurol Neurosurg Psychiatry. 2004. PMID: 14742591 Free PMC article. - Neuroprotective effects of psychotropic drugs in Huntington's disease.
Lauterbach EC. Lauterbach EC. Int J Mol Sci. 2013 Nov 15;14(11):22558-603. doi: 10.3390/ijms141122558. Int J Mol Sci. 2013. PMID: 24248060 Free PMC article. Review. - Early Detection of Huntington Disease.
Paulsen JS. Paulsen JS. Future Neurol. 2010 Jan;5(1):10.2217/fnl.09.78. doi: 10.2217/fnl.09.78. Future Neurol. 2010. PMID: 24348095 Free PMC article. - Neuroimaging in Dementia.
Staffaroni AM, Elahi FM, McDermott D, Marton K, Karageorgiou E, Sacco S, Paoletti M, Caverzasi E, Hess CP, Rosen HJ, Geschwind MD. Staffaroni AM, et al. Semin Neurol. 2017 Oct;37(5):510-537. doi: 10.1055/s-0037-1608808. Epub 2017 Dec 5. Semin Neurol. 2017. PMID: 29207412 Free PMC article. Review. - The role of the human globus pallidus in Huntington's disease.
Singh-Bains MK, Waldvogel HJ, Faull RL. Singh-Bains MK, et al. Brain Pathol. 2016 Nov;26(6):741-751. doi: 10.1111/bpa.12429. Brain Pathol. 2016. PMID: 27529459 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical